AGN-2979
Experimental drug
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number ATC Code PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
AGN-2979 is an experimental drug that has been investigated for its potential therapeutic effects. It is primarily studied in the context of neurological disorders and psychiatric conditions. The drug is part of a class of compounds known as receptor antagonists, which work by blocking specific receptors in the brain and nervous system.
Mechanism of Action[edit | edit source]
AGN-2979 functions as a receptor antagonist, specifically targeting the serotonin receptors. By inhibiting these receptors, the drug aims to modulate the levels of serotonin in the brain, which is a key neurotransmitter involved in mood regulation, anxiety, and other cognitive functions.
Potential Applications[edit | edit source]
The primary focus of research on AGN-2979 has been its application in treating conditions such as depression, anxiety disorders, and schizophrenia. Preliminary studies suggest that it may help alleviate symptoms by restoring the balance of neurotransmitters in the brain.
Clinical Trials[edit | edit source]
As of the latest updates, AGN-2979 is in the early stages of clinical trials. These trials are designed to assess its safety, efficacy, and potential side effects in human subjects. The outcomes of these trials will determine whether AGN-2979 can proceed to later stages of drug development and potential approval by regulatory agencies.
Side Effects[edit | edit source]
Like many experimental drugs, AGN-2979 may have side effects. Commonly reported side effects in early trials include nausea, headache, and dizziness. More serious side effects are still under investigation and will be closely monitored in ongoing studies.
Conclusion[edit | edit source]
AGN-2979 represents a promising avenue of research in the field of neuropharmacology. Its development is being closely watched by the medical community, and further studies will elucidate its potential as a therapeutic agent.
See Also[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
